Valeant Pharmaceuticals shares plunged Monday on news that the Canadian company is in the crosshairs of U.S. legislators as a result of steep price hikes on two heart drugs its sells.
from CBC | Health News http://ift.tt/1VkVYl2
ABOUT THE AUTHOR
Hello We are OddThemes, Our name came from the fact that we are UNIQUE. We specialize in designing premium looking fully customizable highly responsive blogger templates. We at OddThemes do carry a philosophy that: Nothing Is Impossible
0 commentaires:
Enregistrer un commentaire